
Guys had a whole menu of things that could work on erectile dysfunction. Now, erectile dysfunction is not desire disorder.
It means you've got desire and it doesn't work and the purple little, blue pill, Viagra, is one of a series of drugs which increase blood flow to the penis, and when you give those kinds of drugs to women, nothing happens.
Acquired HSDD refers to HSDD that develops in a patient who previously had no problem with sexual desire. ADDYI is not indicated for use in men. Hypoactive Sexual Desire Disorder (HSDD), commonly called “decreased libido”, affects approximately 10% of the female population across all age groups, according to the International Society for Sexual Medicine. With several national news organizations introducing the “little pink pill”, I thought it would be a good time to review HSDD. Signs and symptoms that might suggest a low sex drive include: Few, if any, thoughts or fantasies about sex Bothered by the lack of sex drive There are several things that can contribute to a decreased libido, including: Medical illnessHigh blood pressureCancerDiabetesCoronary artery diseaseNeurological disorders Medications such as birth control pills or antidepressants Lifestyle habitsToo much alcohol consumptionSmoking (which can decrease blood flow and decrease arousal)Street drugs Smoking (which can decrease blood flow and decrease arousal) Psychological issuesDepressionAnxietyStressPoor body imageHistory of sexual abuseHistory of negative sexual experience Relationship issuesLack of closenessUnresolved conflictsLack of communication as to your needsInfidelity Lack of communication as to your needs There are currently no FDA approved medications for the treatment of HSDD.
However, on June 4, 2015, an advisory committee to the Food and Drug Administration (FDA) recommended approval, with conditions, of the drug Flibanserin. This medication is for the treatment of premenopausal women with HSDD. It would be the first medication approved to treat HSDD. The advocacy group called “Even the Score” had a large presence at the FDA approval committee meeting. Their campaign supports gender equality when it pertains to drugs to treat sexual dysfunction.
Many are concerned that the FDA has a gender bias when it comes to approving drugs for women. Currently the FDA has approved 26 medications that treat male sexual dysfunction and none that treat women’s. It acts on the dopamine and serotonin receptors in the brain. Thus, only women with a dopamine and serotonin imbalance are candidates for this drug. This is not for everyone and only upon completion of a thorough examination should a woman with the diagnosis of Hypoactive Sexual Desire Disorder be prescribed this medication. They get more blood flow down there but they're not excited. So to call this female Viagra is way wrong.
| Product | Dosage | Quantity + Bonus | Price | |
|---|---|---|---|---|
| Levitra Original | 20mg | 8 Pills | 65.05€ 61.95€ | |
| Cialis Generic | 60mg | 60 + 4 Pills | 145.06€ 138.15€ | |
| Kamagra Polo | 100mg | 272 + 12 Pills | 622.94€ 593.28€ | |
| Cialis Generic | 40mg | 180 + 10 Pills | 277.29€ 264.09€ | |
| Cialis Black | 80mg | 90 + 6 Pills | 207.88€ 197.98€ | |
| Viagra Original | 100mg | 14 + 2 Pills | 89.03€ 84.79€ | |
| Cialis Generic | 2.5mg | 60 + 4 Pills | 83.43€ 79.46€ | |
| Viagra Generic | 150mg | 360 + 10 Pills | 423.48€ 403.31€ | |
| Cialis Black | 80mg | 270 + 10 Pills | 502.88€ 478.93€ | |
| Kamagra Soft Tabs | 100mg | 32 Pills | 120.11€ 114.39€ | |
| Viagra Generic | 150mg | 30 + 2 Pills | 72.32€ 68.88€ | |
| Kamagra Oral Jelly | 100mg | 10 Sachets | 54.55€ 51.95€ | |
| Levitra Professional | 20mg | 180 + 4 Pills | 502.31€ 478.39€ | |
| Cialis Generic | 5mg | 120 + 6 Pills | 132.92€ 126.59€ | |
| Viagra Super Active | 100mg | 270 + 30 Pills | 390.61€ 372.01€ |
Interviewer: Because Viagra solves a mechanical problem. Dr.
| Side Effect | Description | Risk Factors | Recommendations |
|---|---|---|---|
| Nausea | Feeling of sickness after intake | Sensitive stomachs | Take with food |
| Headaches | Mild to moderate headaches | Dehydration, stress | Stay hydrated, reduce stress |
| Hormonal Disruption | Imbalance caused by hormonal ingredients | Overuse, interaction with medications | Consult a doctor before use |
| Allergic Reactions | Rash, swelling, itching | Allergies to herbal ingredients | Discontinue use, seek medical help |
Jones: Exactly, and in women it's an internal desire problem.
| Benefit | Description | Evidence Level | Common Side Effects |
|---|---|---|---|
| Mood Stabilization | Helps reduce anxiety and improve mood | Moderate | Headaches, nausea |
| Increased Libido | Boosts sexual desire | Anecdotal, some studies | Fatigue, dizziness |
| Better Sleep | Promotes better quality sleep | Consistent reports | Drowsiness, dry mouth |
| Energy Boost | Provides a natural increase in daytime alertness | Limited clinical data | Jitters, insomnia |
So they had this drug and they did a randomized trial where women were given placebo versus this drug at different doses and lo and behold, there was a little difference. Now I want to talk about, if I were going to counsel a patient, what kind of difference was there with flibanserin? It turns out about 10% of women respond.
But in women it wasn't that great as an anti-depressant, but it actually had a little boost in sexual interest. So they then went on to say, "We'll take this drug which works on the neurotransmitters in the brain," so this works on dopamine, it increases dopamine, the reward center. It increases norepinephrine, another rewards center and it decreases serotonin. So they decided they'd work on it and see how it really worked in women who complained of hypoactive sexual desire disorder. Is this a disease or do women, when they get to a certain part of life, is not having much of a sex drive perfectly normal and the answer is it's so common, that yes, it's normal.
It's been suggested that as many of 40% of women at some time in their life have a period of time of two weeks when they're not interested in sex. So if I ask women, "Has there been a time in the last year for longer than two weeks when you weren't interested in sex?" Most women are going to respond, "Oh shoot yeah. Not being interested in sex isn't a disease. But then the question you ask is, "How much does this distress you?" and you say, "Well I don't care, it's fine by me. My husband is a little tweaked about it, but fine," or, "This has really destroyed our relationship. So if you give this drug to 100 women, and you give placebo to 100 women, 34 out of 100 of women with placebo will get better, they'll have more interest in sex and they'll have more sexually satisfying sexual activity.
| Aspect | Description | Usage Frequency | Intended Benefits |
|---|---|---|---|
| What is the Pink Pill | A supplement or medication aimed at improving women's health | Daily, Weekly, As prescribed | Enhances mood, energy, libido |
| Main Ingredients | Melatonin, herbal extracts, vitamins | varies | hormonal balance, vitality |
| Target Audience | Women aged 25-50 | N/A | Women's health improvement |
So out of 100 people, about 10 will actually be responding because of the drug, and we don't know when I'm sitting in the office, which 10% those are.
It's a drug that you have to take every day and it has side effects.
My husband is looking forward to the kind of closeness we had early in our relationship, the intimacy, frequency, and now, it's not there." So although not having desire is normal for women, if it was a change in desire and if it causes distress, should we medicate that? My feeling for a patient who comes to me with this complaint, and about 10% of women have this condition, where they have a decrease in their desire and it causes them distress. Those are the two things you have to have. And buy super p force jelly for women for whom it causes distress, we have not had anything that works. "Take a couple of drinks and see how you feel." Or, we tried testosterone patches and that's a whole separate issue and that didn't make a big difference, so we really didn't have anything. But what can you expect if you are one of those 10%, what can you expect to see in terms of difference? Well the other reason the FDA was not excited was the fact that the average number of satisfying sexual activities was 2.8 in the study group and when they took placebo it went to 3.7 per month, 2.7 happy times in bed per month.
(That is, assuming the FDA actually approves it.) If approved, “the little pink pill” will be as popular a term as the “little blue pill” has been for men. Interviewer: The little pink pill that helps women's sex drive. We're going to ask Dr. Kirtly Parker Jones to tell us more about that next on The Scope. Announcer: Covering all aspects of women's health.
This is the "Seven Domains of Women's Health" with Dr. Kirtly Jones, on The Scope. Interviewer: Dr. Jones, we've been reading much, as I would imagine our listeners have and seen the news coverage on the little pink pill, it's being called "the female Viagra" which is probably not accurate and we'll talk about that in a second as well. How would you decide whether or not you would recommend it or not recommend it to a patient?
There are benefits, there are drawbacks, the FDA didn't approve it twice and now they've approved it, just a lot of questions. So first of all what is this pill gel erectile dysfunction and what does it do? Some years ago a drug company in Europe was looking for a new, better anti-anxiety and anti-depressant drug that wouldn't have sexual side effects. A lot of the drugs in the SSRI group can cause problems with libido. So they have this drug called flibanserin and they rolled it out, looking at it as an anti-depressant and they found that in men it didn't change their libido one way or the other and it didn't work that great as an anti-depressant. And then with placebo, it went to 3.7.
So about one extra happy time when you just took placebo, and it went from 2.8 on flibanserin before they started, to 4.5 on flibanserin. So that was about two extra happy times a month.
Concomitant use of multiple weak CYP3A4 inhibitors that may include herbal supplements (e.g., ginkgo, resveratrol) or non-prescription drugs (e.g., cimetidine) could also lead to clinically relevant increases in flibanserin concentrations that may increase the risk of hypotension and syncope. Central Nervous System (CNS) Depression (e.g., Somnolence, Sedation): Can occur with ADDYI alone and is exacerbated by other CNS depressants. The risk of CNS depression is also increased if ADDYI is taken during waking hours. Patients should avoid activities requiring full alertness (e.g., operating machinery or driving) until at least six hours after each dose and until they know how ADDYI affects them. Hypotension and Syncope with ADDYI Alone: The use of ADDYI - without other concomitant medications known to cause hypotension or syncope - can cause hypotension and syncope.
The risk is increased if ADDYI is taken during waking hours or if higher than the recommend dose is taken. Syncope and Hypotension in Patients with Hepatic Impairment: Any degree of hepatic impairment significantly increases flibanserin concentrations, which can lead to hypotension and syncope. ADDYI is contraindicated in patients with hepatic impairment. Hypersensitivity Reactions: Reactions including anaphylaxis, reactions consistent with angioedema, pruritus, and urticaria have been reported with ADDYI. Immediately discontinue ADDYI and initiate appropriate treatment if hypersensitivity reaction occurs.
Oral Contraceptives and Other Weak CYP3A4 Inhibitors: Increases flibanserin exposures and incidence of adverse reactions. Strong CYP2C19 Inhibitors: Increases flibanserin exposure which may increase risk of hypotension, syncope, and CNS depression. CYP3A4 Inducers: Use of ADDYI not recommended, flibanserin concentrations substantially reduced Digoxin: Increases digoxin concentrations, which may lead to digoxin toxicity. Most common adverse reactions (ADDYI incidence ≥2% and higher than libido booster for women placebo) are dizziness, somnolence, nausea, fatigue, insomnia, and dry mouth. See Full Prescribing Information and Medication Guide, including Boxed Warning regarding hypotension and syncope in certain settings. So that's one over placebo, per month. So the FDA didn't think that was very impressive.